Durability and Cross-Reactivity of Immune Responses Induced by an AS03-Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew P. Cheng, View ORCID ProfileDonald C. Vinh, Philippe Boutet, Robbert Van Der Most, François Roman, Maria Angeles Ceregido, Nathalie Landry, Marc-André D’Aoust, Brian J. Ward
doi: https://doi.org/10.1101/2021.08.04.21261507
Philipe Gobeil
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Stéphane Pillet
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Iohann Boulay
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Nathalie Charland
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Aurélien Lorin
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Matthew P. Cheng
2The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada
Donald C. Vinh
2The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada
Philippe Boutet
3GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300 Wavre, Belgium
Robbert Van Der Most
4GlaxoSmithKline (Vaccines), rue de l’Institut 89, 1330 Rixensart, Belgium
François Roman
3GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300 Wavre, Belgium
Maria Angeles Ceregido
3GlaxoSmithKline (Vaccines), Avenue Fleming 20, 1300 Wavre, Belgium
Nathalie Landry
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Marc-André D’Aoust
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
Brian J. Ward
1Medicago Inc., Suite 600, 1020 route de l’Église, Québec, QC, G1V 3V9, Canada
2The Research Institute of the McGill University Health Centre, 1001 Decarie Street, Montreal, QC, H4A 3J1, Canada
Article usage
Posted August 26, 2022.
Durability and Cross-Reactivity of Immune Responses Induced by an AS03-Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, Robbert Van Der Most, François Roman, Maria Angeles Ceregido, Nathalie Landry, Marc-André D’Aoust, Brian J. Ward
medRxiv 2021.08.04.21261507; doi: https://doi.org/10.1101/2021.08.04.21261507
Durability and Cross-Reactivity of Immune Responses Induced by an AS03-Adjuvanted Plant-Based Recombinant Virus-Like Particle Vaccine for COVID-19
Philipe Gobeil, Stéphane Pillet, Iohann Boulay, Nathalie Charland, Aurélien Lorin, Matthew P. Cheng, Donald C. Vinh, Philippe Boutet, Robbert Van Der Most, François Roman, Maria Angeles Ceregido, Nathalie Landry, Marc-André D’Aoust, Brian J. Ward
medRxiv 2021.08.04.21261507; doi: https://doi.org/10.1101/2021.08.04.21261507
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12545)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4419)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2845)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6764)
- Radiology and Imaging (1487)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)